Sagredo et al. showed that RNA editing in 3′ UTRs and exonic regions are increased in breast cancer cells compared to immortalized non-malignant cells, and high-level of ADAR1 expression was associated with worse clinical outcome and increased editing in 3′UTRs9. Here, ADAR is linked to breast cancer.